Temporary nuclear medicine items 61470 and 61477 – item continuation and one-off fee increase

This page provides information regarding 1 July 2024 changes to the Medicare Benefits Schedule (MBS) temporary nuclear medicine items 61470 and 61477.

Page last updated: 06 June 2024

Temporary MBS items 61470 (whole body or localised study using thallium-201 or single rest myocardial perfusion study using thallium-201) and 61477 (whole body or localised study using gallium) will be available for a further 24 months from 1 July 2024 to 30 June 2026, to continue to support patient access to nuclear medicine imaging services that use thallium-201 and gallium-67.

From 1 July 2024, there will be a one-off increase to the schedule fee for MBS item 61470 from $1,126.00 to $1,463.80 and MBS item 61477 from $740.00 to $962.00.

Further information can be found in the factsheet below:

Word Version - Temporary nuclear medicine items 61470 and 61477 – item continuation and one-off fee increase (Word 121 KB)
PDF Version - Temporary nuclear medicine items 61470 and 61477 - item continuation and one-off fee increase (PDF 173 KB)

In this section